Eli Lilly and Company: all 2,262 studies
Page 8 of 23. Open to participants first (177), then studies with results posted, then the rest; newest registration first within each.
- A Study of LY2409021 Formulations in Healthy ParticipantsTerminatedNCT02385084Phase 1Results posted
- A Study of Olaratumab in Japanese Participants With Advanced CancerCompletedNCT02377752Phase 1Results posted
- A Study to Evaluate the Effect of Increased Stomach pH on Evacetrapib in Healthy ParticipantsCompletedNCT02365558Phase 1Results posted
- A Study of Ramucirumab Combination Therapy in Japanese Participants Who Have Advanced Stomach CancerCompletedNCT02359058Phase 1Results posted
- 18F-AV-1451 High Resolution Autopsy StudyCompletedNCT02350634Phase 1Results posted
- A Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic ArthritisCompletedNCT02349295Phase 3Results posted
- A Study of LY3143753 and LY3185643 in Healthy ParticipantsCompletedNCT02342314Phase 1Results posted
- A Study to Measure Baricitinib (LY3009104) Absorption in Healthy ParticipantsCompletedNCT02340104Phase 1Results posted
- A Study of 2 Different Formulations of Blosozumab (LY2541546) in Post Menopausal WomenTerminatedNCT02337387Phase 1Results posted
- Augmenting Flortaucipir Dosimetry EstimatesCompletedNCT02336360Phase 1Results posted
- An Extension Study of Duloxetine in Osteoarthritis and Knee Pain (Extension of F1J-JE-HMGX, NCT02248480)CompletedNCT02335346Phase 3Results posted
- A Study of LY2835219 in Healthy ParticipantsCompletedNCT02327143Phase 1Results posted
- A Study of Olaratumab and Doxorubicin in Participants With Advanced Soft Tissue SarcomaCompletedNCT02326025Phase 1Results posted
- A Study of LY3202626 in Healthy Participants and Participants With Alzheimer's DiseaseCompletedNCT02323334Phase 1Results posted
- A Study of LY900014 Formulations in Healthy ParticipantsCompletedNCT02317575Phase 1Results posted
- A Study of Ramucirumab (LY3009806) in Combination With Capecitabine and Cisplatin in Participants With Stomach CancerCompletedNCT02314117Phase 3Results posted
- A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer, Non-small Cell Lung Cancer, or Melanoma That Has Spread to the BrainCompletedNCT02308020Phase 2Results posted
- A Study of LY2963016 Compared to LANTUS® in Adult Participants With Type 2 Diabetes MellitusCompletedNCT02302716Phase 3Results posted
- A Study of LY2623091 in Healthy ParticipantsCompletedNCT02300259Phase 1Results posted
- A Study of Lispro Formulations in Healthy ParticipantsCompletedNCT02293551Phase 1Results posted
- Clinical Evaluation of Flortaucipir F 18CompletedNCT02278367Phase 2Results posted
- Tau Imaging in Professional FightersCompletedNCT02278354Phase 1Results posted
- A Study to Measure the Amount of Evacetrapib That Enters the Blood Stream in Healthy ParticipantsCompletedNCT02271425Phase 1Results posted
- A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis (RA)CompletedNCT02265705Phase 3Results posted
- A Study of LY3022855 In Participants With Breast or Prostate CancerCompletedNCT02265536Phase 1Results posted
- A Study of Baricitinib in Healthy Japanese ParticipantsCompletedNCT02263911Phase 1Results posted
- A Study of Evacetrapib (LY2484595) in Combination With Atorvastatin in Japanese Participants With Primary HypercholesterolemiaTerminatedNCT02260648Phase 3Results posted
- A Study of Evacetrapib (LY2484595) in Japanese Participants With Primary HypercholesterolemiaTerminatedNCT02260635Phase 3Results posted
- A Study of LY2835219 in Healthy ParticipantsCompletedNCT02256267Phase 1Results posted
- A Study of Duloxetine (LY248686) in Participants With Chronic Osteoarthritis and Knee Pain in JapanCompletedNCT02248480Phase 3Results posted
- A Study of Nonsteroidal Aromatase Inhibitors Plus Abemaciclib (LY2835219) in Postmenopausal Women With Breast CancerActive, not recruitingNCT02246621Phase 3Results posted
- A Study of How the Body Breaks Down and Eliminates LY2623091CompletedNCT02242981Phase 1Results posted
- A Study of LY3079514 in Healthy ParticipantsCompletedNCT02242903Phase 1Results posted
- Food-Effect Study in Healthy ParticipantsCompletedNCT02233296Phase 1Results posted
- A Study of Evacetrapib (LY2484595) in Participants With High CholesterolTerminatedNCT02227784Phase 3Results posted
- A Study of Evacetrapib in Healthy Japanese ParticipantsCompletedNCT02226653Phase 1Results posted
- A Study of Tadalafil (LY450190) in Chinese Men With Erectile DysfunctionCompletedNCT02224846Phase 4Results posted
- A Study of LY3164530 in Participants With CancerCompletedNCT02221882Phase 1Results posted
- A Study of LY2409021 in Healthy ParticipantsCompletedNCT02217618Phase 1Results posted
- A Study To Compare the Effects of Insulin Peglispro and Glargine on Insulin Sensitivity and Meal Time Insulin Requirements in Type 2 DiabeticsCompletedNCT02197520Phase 1Results posted
- A Study of LY2623091 in Participants With High Blood PressureCompletedNCT02194465Phase 2Results posted
- A Study of LY2951742 in Participants With Mild to Moderate Osteoarthritis Knee PainTerminatedNCT02192190Phase 2Results posted
- A Study of LY2157299 in Participants With Advanced Hepatocellular CarcinomaCompletedNCT02178358Phase 2Results posted
- Clinical Usability of Intranasal Glucagon in Treatment of HypoglycemiaCompletedNCT02171130Phase 3Results posted
- A Study of Evacetrapib in Participants With Abnormal CholesterolCompletedNCT02168803Phase 1Results posted
- Safety Dose Finding Study of ADVM-043 Gene Therapy to Treat Alpha-1 Antitrypsin (A1AT) DeficiencyCompletedNCT02168686Phase 1/2Results posted
- Tau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy VolunteersCompletedNCT02167594Phase 1Results posted
- A Study of Galcanezumab (LY2951742) in Participants With Migraine HeadacheCompletedNCT02163993Phase 2Results posted
- Study of Evacetrapib (LY2484595) and Warfarin in Healthy ParticipantsCompletedNCT02161731Phase 1Results posted
- A Study of Evacetrapib With Selected Statins in Healthy Chinese ParticipantsCompletedNCT02156492Phase 1Results posted
- A Study of Abemaciclib (LY2835219) in Participants With Previously Treated KRAS Mutated Lung CancerActive, not recruitingNCT02152631Phase 3Results posted
- A Study to Compare and Measure the Effects of Insulin Peglispro (LY2605541) and Glargine on Meal Time Insulin RequirementsCompletedNCT02152384Phase 1Results posted
- A Study of Dulaglutide (LY2189265) in Participants With Type II DiabetesCompletedNCT02152371Phase 3Results posted
- A Study of LY3113593 in Healthy Participants and Participants With Chronic Kidney Disease Treated With HemodialysisCompletedNCT02144285Phase 1Results posted
- A Study to Compare the Effect of a Double Dose of Two Long-acting Insulin Therapies in Participants With Type 2 DiabetesCompletedNCT02132637Phase 3Results posted
- A Study of Cephalexin Liquid for Pediatrics in Healthy Adults ParticipantsCompletedNCT02123472Phase 1Results posted
- A Study of Cephalexin Suspension in Healthy ParticipantsCompletedNCT02123459Phase 1Results posted
- A Study of Cephalexin Capsules in Healthy ParticipantsCompletedNCT02123446Phase 1Results posted
- A Study of LY3050258 in Healthy ParticipantsCompletedNCT02121834Phase 1Results posted
- Florbetapir Calibration to the Centiloid ScaleCompletedNCT02120664Phase 1Results posted
- A Study of LY2835219 in Participants With CancerCompletedNCT02117648Phase 1Results posted
- A Study of LY2409021 in Participants With Type 2 Diabetes MellitusTerminatedNCT02111096Phase 2Results posted
- A Study of 2 Different Formulations of Insulin Lispro in Healthy ParticipantsCompletedNCT02111083Phase 1Results posted
- A Study of Blosozumab (LY2541546) in Postmenopausal Female ParticipantsCompletedNCT02109042Phase 1Results posted
- A Study of LY2605541 (Insulin Peglispro) and Human Insulin Concentrations in Fat TissueCompletedNCT02109029Phase 1Results posted
- A Study of Abemaciclib (LY2835219) Combined With Fulvestrant in Women With Hormone Receptor Positive HER2 Negative Breast CancerActive, not recruitingNCT02107703Phase 3Results posted
- The Feasibility of Florbetapir Quantitation in EuropeCompletedNCT02107599Phase 4Results posted
- A Study of LY2951742 in Healthy Japanese and Caucasian ParticipantsCompletedNCT02104765Phase 1Results posted
- A Study of Abemaciclib (LY2835219) In Participants With Previously Treated Breast Cancer That Has SpreadCompletedNCT02102490Phase 2Results posted
- A Study of Cephalexin in Healthy ParticipantsCompletedNCT02100826Phase 1Results posted
- A Study of LY2409021 on Blood Pressure and Pulse Rate in Participants With Type 2 Diabetes MellitusCompletedNCT02091362Phase 2Results posted
- A Study of Emibetuzumab in Combination With Ramucirumab (LY3009806) in Participants With Advanced CancerCompletedNCT02082210Phase 1/2Results posted
- 18F-AV-1451 and Florbetapir F 18 PET (Positron Emission Tomography) Imaging in Subjects at Risk for Chronic Traumatic EncephalopathyCompletedNCT02079766Phase 2Results posted
- A Study of Abemaciclib (LY2835219) in Combination With Another Anti-cancer Drug in Participants With Lung Cancer (NSCLC)CompletedNCT02079636Phase 1Results posted
- A Comparison of Two Treatment Strategies in Older Participants With Type 2 Diabetes Mellitus (T2DM)TerminatedNCT02072096Phase 4Results posted
- A Study of Ramucirumab (LY3009806) in Participants With Advanced Liver CancerCompletedNCT02069041Phase 1Results posted
- A Study of LY2835219 in Healthy ParticipantsCompletedNCT02059148Phase 1Results posted
- Evaluation of Reader Training ProcessesCompletedNCT02051790Phase 4Results posted
- Imaging Characteristics of a Follow-up 18F-AV-1451 ScanTerminatedNCT02051764Phase 2Results posted
- A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With LupusTerminatedNCT02041091Phase 3Results posted
- A Study of the Safety and Effectiveness of LY3053102 in Participants With Type 2 DiabetesTerminatedNCT02020616Phase 1/2Results posted
- A Study of LY2969822 in Healthy ParticipantsCompletedNCT02018887Phase 1Results posted
- Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI, and AD SubjectsCompletedNCT02016560Phase 2/3Results posted
- A Study of LY2835219 in Japanese Participants With Advanced CancerCompletedNCT02014129Phase 1Results posted
- A Study of LY3009120 in Participants With Advanced Cancer or Cancer That Has Spread to Other Parts of Their BodyTerminatedNCT02014116Phase 1Results posted
- A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid TumorsCompletedNCT02009449Phase 1Results posted
- Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory LossCompletedNCT02008357Phase 3Results posted
- A Study of Galunisertib in Participants With Myelodysplastic SyndromesCompletedNCT02008318Phase 2/3Results posted
- A Study of Axiron® in Healthy ParticipantsCompletedNCT02004132Phase 1Results posted
- Assessment of Intranasal Glucagon in Children and Adolescents With Type 1 DiabetesCompletedNCT01997411Phase 2/3Results posted
- A Study of Insulin Peglispro in Healthy Male Japanese ParticipantsCompletedNCT01995526Phase 1Results posted
- Efficacy and Safety of Nasal Glucagon for Treatment of Hypoglycemia in AdultsCompletedNCT01994746Phase 3Results posted
- A Study of Flortaucipir PET in Healthy Volunteers and Cognitively Impaired SubjectsCompletedNCT01992380Phase 1Results posted
- A Study of LY2928057 in Hemodialysis ParticipantsCompletedNCT01991483Phase 1Results posted
- A Study of Ramucirumab in Treating Japanese Participants With Metastatic Gastric or Gastroesophageal Junction CancerCompletedNCT01983878Phase 2Results posted
- A Study of LY3127760 in Healthy ParticipantsCompletedNCT01968070Phase 1Results posted
- A Study of Baricitinib and Ciclosporin in Healthy ParticipantsCompletedNCT01968057Phase 1Results posted
- A Study of [14C]-LY3023703 in Healthy ParticipantsTerminatedNCT01965782Phase 1Results posted
- A Study of Baricitinib and Simvastatin in Healthy ParticipantsCompletedNCT01960140Phase 1Results posted
- Evaluate the Immunogenicity of a Novel Glucagon FormulationCompletedNCT01959334Phase 3Results posted